HANNAH BURRESS-BROWN: Open Payments
NPI 1760213748 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,226 in 94 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $792 · 2025 $2,226
Food & beverage: $2,043Education: $183
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $827 |
| Janssen Biotech, Inc. | 12 | $449 |
| Phathom Pharmaceuticals, Inc. | 6 | $243 |
| Madrigal Pharmaceuticals | 7 | $168 |
| Gilead Sciences, Inc. | 4 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| QOL Medical, LLC | 2 | $49 |
| Aimmune Therapeutics, Inc. | 3 | $48 |
| Novo Nordisk Inc | 2 | $40 |
Products named: TREMFYA, CREON, LINZESS, VOQUEZNA, REZDIFFRA, Livdelzi, VRAYLAR, XIFAXAN.
Industry payments across OH — which companies pay providers there.
